Prognostic factors correlated with survival in AIDS patients

被引:0
作者
S. Casari
A. Donisi
G. Paraninfo
D. Tomasoni
L. Palvarini
P. Nasta
A. Bergamasco
G.P. Cadeo
G. Carosi
机构
[1] University of Brescia,Infectious and Tropical Diseases Clinic
[2] Departement of Infectious Diseases,undefined
[3] Spedali Civili of Brescia,undefined
来源
European Journal of Epidemiology | 1999年 / 15卷
关键词
AIDS; Prognostic factors; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
The authors present the AIDS cases (CDC '93) observed in Brescia from 1983 to 1994. They observed 1189 subjects (M 84%, F 16%) with a mean age of 32.7 years (intra-venous drug users 75.1%, heterosexuals 14%, homosexuals 9.6%). The mean survival observed was 56.7 weeks from the diagnosis of AIDS (mortality per year 78%). The most frequent AIDS-defining events were Visceral Candidiasis, P.carinii Pneumonia (PCP) and Neurotoxoplasmosis, while the longest and shortest mean survival was for Kaposi's Sarcoma (89 weeks) and Wasting Syndrome (8.4). The mean value of CD4+ lymphocyte counts on AIDS diagnosis was 72.6/μl (1166 cases) and the highest and lowest were in non-Hodgkin's Lymphoma (NHL; 147.6/μl) and Cryptosporidiosis (18.8/μl). Antiretroviral therapy had been given for at least a month in 41.4% subjects (mean treatment duration of 74.8 weeks). The Cox model has demonstrated the favourable effect on survival of high CD4+ lymphocyte counts on diagnosis, antiretroviral therapy, the diagnosis of Tuberculosis (TBC) and PCP as initial markers and the diagnosis of TBC, PCP or Cytomegalovirus infection (CMV) during the entire clinical evolution. Moreover, the unfavourable effect of high age, diagnosis of Progressive Multifocal Leucoencephalopathy (PML), Wasting Syndrome and NHL as initial markers and diagnosis of PML or NHL in any moment of the disease has been demonstrated.
引用
收藏
页码:691 / 698
页数:7
相关论文
共 50 条
  • [1] Prognostic factors correlated with survival in AIDS patients
    Casari, S
    Donisi, A
    Paraninfo, G
    Tomasoni, D
    Palvarini, L
    Nasta, P
    Bergamasco, A
    Cadeo, GP
    Carosi, G
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (08) : 691 - 698
  • [2] Survival prognostic factors in patients with uterine carcinosarcoma
    Malca, Magaly T.
    Lopez, Aldo B.
    Santos, Carlos O.
    Alvarez, Manuel L.
    REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2013, 59 (02): : 119 - 124
  • [3] Prognostic Factors for Survival in Patients With Unresectable Pancreatic Cancer
    Weber, Andreas
    Kehl, Victoria
    Mittermeyer, Tobias
    Herberich, Esther
    Roethling, Nadine
    Schmid, Roland M.
    Prinz, Christian
    PANCREAS, 2010, 39 (08) : 1247 - 1253
  • [4] Prognostic Factors for Survival in Patients with Metastatic Colon Carcinoma
    Yilmaz, Feride
    Karabulut, Cevriye Ceyda
    Ozdemir, Feyyaz
    Aydin, Fazil
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (03): : 148 - 154
  • [5] Prognostic factors related with survival in patients with pancreatic adenocarcinoma
    Ahmet Bilici
    World Journal of Gastroenterology, 2014, (31) : 10802 - 10812
  • [6] Prognostic factors related with survival in patients with pancreatic adenocarcinoma
    Bilici, Ahmet
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10802 - 10812
  • [7] Survival probability and prognostic factors for breast cancer patients in Vietnam
    Lan, Nguyen H.
    Laohasiriwong, Wongsa
    Stewart, John F.
    GLOBAL HEALTH ACTION, 2013, 6 : 23 - 31
  • [8] Prognostic factors to predict postoperative survival in patients with recurrent glioblastoma
    Hansen, Stella T. E.
    Jacobsen, Kasper S.
    Kofoed, Mikkel S.
    Petersen, Jeanette K.
    Boldt, Henning B.
    Dahlrot, Rikke H.
    Schulz, Mette K.
    Poulsen, Frantz R.
    WORLD NEUROSURGERY-X, 2024, 23
  • [9] Glioblastoma: Clinical characteristics, prognostic factors and survival in 492 patients
    Stark, Andreas M.
    van de Bergh, Julia
    Hedderich, Juergen
    Mehdorn, H. Maximilian
    Nabavi, Arya
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (07) : 840 - 845
  • [10] Prognostic factors for survival in cervical cancer patients with bone metastasis
    Kanayama, T.
    Mabuchi, S.
    Shimura, K.
    Hisamatsu, T.
    Isohashi, F.
    Hamasaki, T.
    Kimura, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (03) : 290 - 293